David E. Zembower

1.4k total citations
26 papers, 1.1k citations indexed

About

David E. Zembower is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, David E. Zembower has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Organic Chemistry and 6 papers in Infectious Diseases. Recurrent topics in David E. Zembower's work include HIV/AIDS drug development and treatment (6 papers), Cancer therapeutics and mechanisms (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). David E. Zembower is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Cancer therapeutics and mechanisms (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). David E. Zembower collaborates with scholars based in United States, Australia and Iceland. David E. Zembower's co-authors include Lance Stewart, Alex B. Burgin, Mark Cushman, Yves Pommier, M.D. Feese, Bart L. Staker, Heping Zhang, Michael T. Flavin, Matthew M. Ames and Ze‐Qi Xu and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

David E. Zembower

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Zembower United States 16 645 481 195 170 147 26 1.1k
Theodore Johnson United States 15 936 1.5× 454 0.9× 107 0.5× 139 0.8× 181 1.2× 17 1.5k
Jim Iley United Kingdom 22 468 0.7× 902 1.9× 74 0.4× 126 0.7× 165 1.1× 101 1.5k
José N. Domínguez Venezuela 19 541 0.8× 1.1k 2.2× 117 0.6× 193 1.1× 88 0.6× 40 1.7k
Jaime Charris Venezuela 21 508 0.8× 1.1k 2.3× 103 0.5× 137 0.8× 83 0.6× 101 1.6k
Adriana Chilin Italy 23 668 1.0× 1.0k 2.1× 153 0.8× 246 1.4× 147 1.0× 100 1.6k
Süreyya Ölgen Türkiye 21 341 0.5× 532 1.1× 110 0.6× 90 0.5× 72 0.5× 67 921
Gyula Schneider Hungary 26 956 1.5× 1.3k 2.7× 135 0.7× 146 0.9× 142 1.0× 145 1.9k
Guillaume Le Baut France 18 280 0.4× 612 1.3× 112 0.6× 101 0.6× 65 0.4× 77 1.0k
Chung‐Kyu Ryu South Korea 23 390 0.6× 900 1.9× 410 2.1× 109 0.6× 67 0.5× 67 1.3k
Antonella Peduto Italy 19 290 0.4× 341 0.7× 137 0.7× 134 0.8× 85 0.6× 29 869

Countries citing papers authored by David E. Zembower

Since Specialization
Citations

This map shows the geographic impact of David E. Zembower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Zembower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Zembower more than expected).

Fields of papers citing papers by David E. Zembower

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Zembower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Zembower. The network helps show where David E. Zembower may publish in the future.

Co-authorship network of co-authors of David E. Zembower

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Zembower. A scholar is included among the top collaborators of David E. Zembower based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Zembower. David E. Zembower is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zembower, David E., Mary J. Kuffel, Matthew M. Ames, et al.. (2012). Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents. Anti-Cancer Agents in Medicinal Chemistry. 12(9). 1117–1131. 8 indexed citations
2.
Davies, D.R., B. Mamat, Ólafur Þ. Magnússon, et al.. (2010). Corrections to Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography. Journal of Medicinal Chemistry. 53(5). 2330–2331. 1 indexed citations
3.
4.
Zhang, Jun, et al.. (2009). Synthesis and structural assignment of two major metabolites of the LTA4H inhibitor DG-051. Bioorganic & Medicinal Chemistry Letters. 19(22). 6275–6279. 3 indexed citations
5.
Davies, D.R., B. Mamat, Ólafur Þ. Magnússon, et al.. (2009). Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography. Journal of Medicinal Chemistry. 52(15). 4694–4715. 99 indexed citations
6.
Chen, Wei, Glenn L. Stahl, Michael Krohn, et al.. (2009). Development of a Scalable Synthetic Process for DG-051B, A First-in-Class Inhibitior of LTA4H. Organic Process Research & Development. 13(6). 1177–1184. 18 indexed citations
7.
Staker, Bart L., M.D. Feese, Mark Cushman, et al.. (2005). Structures of Three Classes of Anticancer Agents Bound to the Human Topoisomerase I−DNA Covalent Complex. Journal of Medicinal Chemistry. 48(7). 2336–2345. 446 indexed citations
8.
Iyer, Mani S., et al.. (2002). Efficient reversed-phase purification of a hydrophobic reaction product following Mitsunobu-mediated glycosylation. Journal of Chromatography A. 944(1-2). 263–267. 2 indexed citations
9.
Zembower, David E., et al.. (1999). Indolocarbazole poisons of human topoisomerase I: Regioisomeric analogues of ED-110. Bioorganic & Medicinal Chemistry Letters. 9(2). 145–150. 26 indexed citations
10.
Zembower, David E., et al.. (1999). Synthesis of 5,8-dimethoxy-3-hydroxy-4-quinolone, a reported inhibitor of HIV RT, and evidence the original proposed structure was incorrect. Bioorganic & Medicinal Chemistry Letters. 9(4). 543–546. 2 indexed citations
11.
Zembower, David E., Yuh‐Meei Lin, Michael T. Flavin, Fa‐Ching Chen, & Brent E. Korba. (1998). Robustaflavone, a potential non-nucleoside anti-hepatitis B agent. Antiviral Research. 39(2). 81–88. 51 indexed citations
12.
Xu, Ze‐Qi, Robert W. Buckheit, Michael T. Flavin, et al.. (1998). In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI. Bioorganic & Medicinal Chemistry Letters. 8(16). 2179–2184. 40 indexed citations
13.
Zembower, David E. & Heping Zhang. (1998). Total Synthesis of Robustaflavone, a Potential Anti-Hepatitis B Agent. The Journal of Organic Chemistry. 63(25). 9300–9305. 62 indexed citations
14.
Zembower, David E., Michael T. Flavin, Ze‐Qi Xu, et al.. (1997). Structural Analogues of the Calanolide Anti-HIV Agents. Modification of the trans-10,11-Dimethyldihydropyran-12-ol Ring (Ring C). Journal of Medicinal Chemistry. 40(6). 1005–1017. 64 indexed citations
15.
Zembower, David E., Cheryl L. Neudauer, Myra Wick, & Matthew M. Ames. (1996). Peptide boronic acids Versatile synthetic ligands for affinity chromatography of serine proteinases*. International journal of peptide & protein research. 47(5). 405–413. 11 indexed citations
16.
Khilevich, Albert, Michael T. Flavin, Lin Lin, et al.. (1996). Synthesis of (+)-calanolide A, an anti-HIV agent, Via enzyme-catalyzed resolution of the aldol products. Tetrahedron Asymmetry. 7(11). 3315–3326. 29 indexed citations
17.
Zembower, David E., Judith A Gilbert, & Matthew M. Ames. (1993). Enantiospecific syntheses of .alpha.-(fluoromethyl)tryptophan analogs: interactions with tryptophan hydroxylase and aromatic L-amino acid decarboxylase. Journal of Medicinal Chemistry. 36(3). 305–313. 17 indexed citations
18.
Glauser, Tracy A., Albert N. Nelson, David E. Zembower, James J. Lipsky, & R. M. Weinshilboum. (1993). Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase.. Journal of Pharmacology and Experimental Therapeutics. 266(1). 23–32. 24 indexed citations
19.
Zembower, David E., Chih Min Kam, James C. Powers, & Leon H. Zalkow. (1992). Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G. Journal of Medicinal Chemistry. 35(9). 1597–1605. 32 indexed citations
20.
Gupton, John T., David E. Zembower, & John F. Miller. (1988). Two Convenient Syntheses of 2-Aryl-1-Cyano-1-Propenes From Quaternary Ammonium Salts. Synthetic Communications. 18(15). 1891–1903. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theodore Johnson Breakdown of academic impact, for papers by Jim Iley Breakdown of academic impact, for papers by José N. Domínguez Breakdown of academic impact, for papers by Jaime Charris Breakdown of academic impact, for papers by Adriana Chilin Breakdown of academic impact, for papers by Süreyya Ölgen Breakdown of academic impact, for papers by Gyula Schneider Breakdown of academic impact, for papers by Guillaume Le Baut Breakdown of academic impact, for papers by Chung‐Kyu Ryu Breakdown of academic impact, for papers by Antonella Peduto
Rankless by CCL
2026